|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Dreyling, M.; Aukema, S. M.; Rosenwald, A.; Canoni, D.; Rymkiewicz, G.; Thorns, C.; Hartmann, S.; Kluin-Nelemans, H.; Hermine, O.; Klapper, W. und Hoster, E.
(2017):
P53 but not SOX11 IHC has prognostic value independent of MIPI and Ki-67 in prospective trials of the European-MCL Network.
In: Oncology Research and Treatment, Bd. 40: S. 69
Valent, P.; Akin, C.; Hartmann, K.; George, T. I.; Sotlar, K.; Peter, B.; Gleixner, K. V.; Blatt, K.; Sperr, W. R.; Manley, P. W.; Hermine, O.; Kluin-Nelemans, H. C.; Arock, M.; Horny, H.-P.; Reiter, A. und Gotlib, J.
(2017):
Midostaurin: a magic bullet that blocks mast cell expansion and activation.
In: Annals of Oncology, Bd. 28, Nr. 10: S. 2367-2376
Pott, C.; Delfau, M.; Macintyre, E.; Ribrag, V.; Klapper, W.; Unterhalt, M.; Kneba, M.; Hiddemann, W.; Hermine, O.; Kluin-Nelemans, H.; Dreyling, M. und Hoster, E.
(2017):
Implications of deep molecular response after induction and in maintenance treatment in elderly patients with mantle cell lymphoma: updated results of the randomized EU-MCL elderly trial.
In: Oncology Research and Treatment, Bd. 40: S. 13
Dreyling, M.; Campo, E.; Hermine, O.; Jerkeman, M.; Gouill, S. le; Rule, S.; Shpilberg, O.; Walewski, J. und Ladetto, M.
(2017):
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
In: Annals of Oncology, Bd. 28: S. 62-71
Reiter, A.; Kluin-Nelemans, H. C.; George, T.; Akin, C.; DeAngelo, D. J.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Schwaab, J.; Jawhar, M.; Sternberg, D.; Berkowitz, N.; Niolat, J.; Labed, A. Huntsman; Hartmann, K.; Horny, H.-P.; Valent, P. und Gotlib, J.
(2017):
Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls.
In: Haematologica, Bd. 102: S. 321-322